ReNeuron Group plc (the “Company”) (AIM: RENE), a leading UK-based stem cell therapy development company, is pleased to announce that it has been awarded a £1.8 million grant from Innovate UK to further advance its next generation commercial cell therapy manufacturing capabilities.

Read more..

Back